Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31624922 | 0.99 | LPL (0.43) | LPLLIPGPRMT5WDR77ROCK1 | |
| SCHEMBL17070766 | 0.92 | LPL (0.42) | LPLLIPGPRMT5WDR77ROCK1 | |
| SCHEMBL21689732 | 0.91 | LPL (0.35) | LPLLIPGPRMT5WDR77BACE1 | |
| SCHEMBL31624712 | 0.90 | LPL (0.43) | LPLLIPGPRMT5WDR77ROCK1 | |
| SCHEMBL26639956 | 0.88 | LIPG (0.43) | LPLLIPGPRMT5WDR77BACE1 | |
| SCHEMBL26639914 | 0.86 | LIPG (0.43) | LPLLIPGPRMT5WDR77BACE1 | |
| SCHEMBL30953162 | 0.85 | LIPG (0.51) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL13227406 | 0.84 | LPL (0.40) | LPLLIPGPRMT5WDR77BACE1 | |
| SCHEMBL15895327 | 0.84 | LPL (0.40) | LPLLIPGPRMT5WDR77BACE1 | |
| SCHEMBL27192771 | 0.83 | LIPG (0.43) | LPLLIPGPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
| WO-2021034081-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2021-02-25 | — | — | WO | disclosed |
| WO-2020027463-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 | 2020-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | OR10J3, TRPA1, TRPM4 | LPL 352/4885LIPG 630/4885PRMT5 4421/4885 |
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | OR10J3, TRPA1, TRPM4 | LPL 352/4885LIPG 630/4885PRMT5 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.